Open AccessDOAJ SealDOAJCrossrefOpenAlex
Cancer Biology & Therapy
Metadata for this journal is being automatically enriched from connected scholarly data sources.
Journal information
- Publisher
- Taylor & Francis Group
- Subjects
- cancer biology · Cancer Cells and Metastasis · Cancer Research and Treatments · cancer therapy · Cancer-related Molecular Pathways · Cancer, Hypoxia, and Metabolism · Cell death mechanisms and regulation · chemotherapy · Epigenetics and DNA Methylation · MicroRNA in disease regulation · molecular oncology · Neoplasms. Tumors. Oncology. Including cancer and carcinogens · oncology · RNA modifications and cancer
- Country
- GB
- Languages
- EN
- ISSN
- 1538-4047
- E-ISSN
- 1555-8576
- ISSN-L
- 1538-4047
- Open access
- Yes
- OA since
- 2022
- Publication years
- 1898–2026
- APC (summary)
- —
- Website
- Visit journal ↗
Journal Classification
Classification is derived from this journal’s 2024–2025 publications using the OpenAlex taxonomy.
- Classification
- Field / Subfield
- Primary Field
- Biochemistry, Genetics and Molecular Biology
- Primary Subfield
- Molecular Biology
- Domain
- Life Sciences
- Confidence
- Low
- Publications classified
- 203
- Classification version
- OAJF Classification v1.1
APC records
- OPENALEX · 2026
- 2,710 EUR
- OPENALEX · 2026
- 2,335 GBP
- OPENALEX · 2026
- 2,970 USD
- DOAJ · 2026
- 4,595 AUD
- DOAJ · 2026
- 3,300 USD
- DOAJ · 2026
- 3,170 EUR
- DOAJ · 2026
- 2,640 GBP
